Alternative approaches to circumvent P-gp-mediated drug resistance include the development of nanoparticle-based drug delivery systems that can bypass P-gp efflux, and the use of gene silencing techniques like siRNA to downregulate P-gp expression. Additionally, combining P-gp inhibitors with other therapeutic agents is being investigated to enhance the efficacy of chemotherapy.
